Drug application
AMPHOTEC (AMPHOTERICIN B)
Drugs@FDA NDA 050729 · ALKOPHARMA USA
Key facts
| Drug name | AMPHOTEC |
|---|---|
| Active ingredients | AMPHOTERICIN B |
| Application type | NDA |
| Application number | 050729 |
| Company | ALKOPHARMA USA |
| Dosage forms | INJECTABLE, LIPID COMPLEX, INJECTION |
| Strength | 50MG/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Nov 22, 1996 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.